Your browser doesn't support javascript.
loading
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Lucero, Olivia M; Lee, Ji-Ann; Bowman, Jenna; Johnson, Kara; Sapparapu, Gopal; Thomas, John K; Fan, Guang; Chang, Bill H; Thiel-Klare, Karina; Eide, Christopher A; Okada, Craig; Palazzolo, Mike; Lind, Evan; Kosaka, Yoko; Druker, Brian J; Lydon, Nicholas; Bowers, Peter M.
Affiliation
  • Lucero OM; Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
  • Lee JA; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Bowman J; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Johnson K; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Sapparapu G; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.
  • Thomas JK; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Fan G; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.
  • Chang BH; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Thiel-Klare K; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Eide CA; Department of Pathology and Clinical Laboratory Medicine, Oregon Health & Science University, Portland, Oregon.
  • Okada C; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Palazzolo M; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon.
  • Lind E; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon.
  • Kosaka Y; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Druker BJ; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.
  • Lydon N; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.
  • Bowers PM; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.
Clin Cancer Res ; 29(20): 4230-4241, 2023 Oct 13.
Article in En | MEDLINE | ID: mdl-37199721
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Lymphoma, T-Cell Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Lymphoma, T-Cell Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: